Leading research organisations announce top-tier, open access journal for biomedical and life sciences
27 June 2011
The three organisations aim to establish a new journal that will attract and define the very best research publications from across these fields. All research published in the journal will make highly significant contributions that will extend the boundaries of scientific knowledge.
A team of highly regarded, experienced and actively practising scientists will ensure fair, swift and transparent editorial decisions followed by rapid online publication. The first issue of the journal, whose name has yet to be decided, is expected to be published in the summer of 2012.
The three research organisations developed their plans following a workshop in 2010 at HHMI's Janelia Farm Research Campus attended by a number of leading scientists. The participants concluded that there was a need for a model of academic publishing that better suits the needs of the research community.
Dr Robert Tjian, President of the Howard Hughes Medical Institute, says: "The message from the research community was clear: we are fortunate to have many excellent journals, but there is need for a different, more appropriate and efficient publishing model."
Professor Herbert Jäckle, Vice President of the Max Planck Society, says: "A journal which aims to represent and publish the very best research outcomes needs an editorial team of experienced - and, crucially, actively practising - scientists. It must also be editorially independent of those who provide the financial support."
Sir Mark Walport, Director of the Wellcome Trust, says: "We will attract the most outstanding science for publication by establishing a journal in which researchers have confidence in robust editorial decisions taken by their scientific peers. This will be a journal for scientists edited by scientists. The ethos of the journal will be to avoid asking authors to make extensive modifications or perform endless additional experiments before a paper can be published."
Recruitment is under way for an Editor-in-Chief who - like each member of the journal's editorial team - will be an experienced, active scientist. The editorial team will be editorially independent of the funders. They will rely on their scientific expertise and active research experience to identify the best papers, make scientifically based judgments and exercise leadership in steering these papers through peer review.
The journal will employ an open and transparent peer review process in which papers will be accepted or rejected as rapidly as possible, generally with only one round of revisions, and with limited need for modifications or additional experiments. For transparency, reviewers' comments will be published anonymously.
As the journal will only exist online, it offers an opportunity to create a journal and article format that will exploit the potential of new technologies to enable improved data presentation. The journal will be an open access journal: the entire content will be freely available for all to read, to reproduce and for unrestricted use. This open access system will also enhance opportunities to share content and to more directly engage the reader.
The three organisations have made a commitment to cover the costs of launching the journal to ensure its success. The long-term business model will be developed by the incoming Editor-in-Chief and the team they build.
Senior Media Officer
T +44 (0)20 7611 7329
Avice A Meehan
Vice President for Communications and Public Affairs
Howard Hughes Medical Institute
T +1 301-215-8646
Dr Christina Beck
Head of Press and Public Relations
Max Planck Society
T +49 89 2108 1275
Notes for editors
About the Howard Hughes Medical Institute
The Howard Hughes Medical Institute plays a powerful role in advancing scientific research and education in the United States. Its scientists, located across the United States and around the world, have made important discoveries that advance both human health and our fundamental understanding of biology. The Institute also aims to transform science education into a creative, interdisciplinary endeavour that reflects the excitement of real research.
About the Max Planck Society
The Max Planck Society for the Advancement of Science is an independent, non-profit research organisation. The primary goal of the Max Planck Society is to promote research at its own institutes. The Max Planck institutes perform basic research in the interest of the general public in the natural sciences, life sciences, social sciences, and the humanities. Currently, the Max Planck Society operates 80 institutes, four of which are in Italy, the Netherlands and the USA.
About the Wellcome Trust
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust's breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests.